会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Methods, agents and devices for removing nucleophilic toxins from
tobacco and tobacco smoke
    • 用于从烟草和烟草烟雾中去除亲核毒素的方法,试剂和装置
    • US6119701A
    • 2000-09-19
    • US23569
    • 1998-02-13
    • Anthony CeramiCarla CeramiPeter Ulrich
    • Anthony CeramiCarla CeramiPeter Ulrich
    • A24D3/10A24D3/14A24B15/00A24B15/10
    • A24D3/14A24D3/10
    • This invention provides methods, devices and agents for the removal of nucleophilic toxins present in tobacco and tobacco smoke, without the removal of nicotine. The filter element of a tobacco smoking device or an air filtration device used in conjunction with a tobacco smoking device may comprise chemical moieties reactive with nucleophilic compounds, or agents that trap nucleophilic compounds may be incorporated into the filter element of tobacco smoking device such as a cigarette, cigar, pipe, or in a separate filter through which tobacco smoke passes before entering the mouth. The agents may also be incorporated into air filters for removing tobacco combustion product toxins from room air. The agents may also be incorporated into smoking or smokeless tobacco to remove toxins.
    • 本发明提供了除去烟草和烟草烟雾中存在的亲核毒素的方法,装置和试剂,而不除去尼古丁。 与烟草吸烟装置一起使用的烟草吸烟装置或空气过滤装置的过滤元件可以包括与亲核化合物反应的化学部分,或者捕获亲核化合物的试剂可以并入烟草吸烟装置的过滤元件中,例如 香烟,雪茄,烟斗,或烟草烟雾在进入口腔之前通过的单独过滤器。 还可以将这些试剂并入空气过滤器中,以从室内空气中除去烟草燃烧产物毒素。 这些药剂也可以并入吸烟或无烟烟草中以去除毒素。
    • 2. 发明授权
    • Methods for removing nucleophilic toxins from tobacco smoke
    • 从烟草烟雾中去除亲核毒素的方法
    • US06615842B1
    • 2003-09-09
    • US09603633
    • 2000-06-26
    • Anthony CeramiCarla CeramiPeter Ulrich
    • Anthony CeramiCarla CeramiPeter Ulrich
    • A24D306
    • A24D3/10A24D3/14
    • This invention provides methods, devices and agents for the removal of nucleophilic toxins present in tobacco and tobacco smoke. The filter element of a tobacco smoking device or an air filtration device used in conjunction with a tobacco smoking device may comprise chemical moieties reactive with nucleophilic compounds, or agents that trap nucleophilic compounds may be incorporated into the filter element of tobacco smoking device such as a cigarette, cigar, pipe, or in a separate filter through which tobacco smoke passes before entering the mouth. The agents may also be incorporated into air filters for removing tobacco combustion product toxins from room air. The agents may also be incorporated into smoking or smokeless tobacco to remove toxins.
    • 本发明提供了用于去除烟草和烟草烟雾中存在的亲核毒素的方法,装置和试剂。 与烟草吸烟装置一起使用的烟草吸烟装置或空气过滤装置的过滤元件可以包括与亲核化合物反应的化学部分,或者捕获亲核化合物的试剂可以并入烟草吸烟装置的过滤元件中,例如 香烟,雪茄,烟斗,或烟草烟雾在进入口腔之前通过的单独过滤器。 还可以将这些试剂并入空气过滤器中,以从室内空气中除去烟草燃烧产物毒素。 这些药剂也可以并入吸烟或无烟烟草中以去除毒素。
    • 5. 发明申请
    • Methods for preventing or treating neuromuscular or muscular conditions by peripherally administered erythropoietin
    • 通过外周给予的促红细胞生成素预防或治疗神经肌肉或肌肉状况的方法
    • US20070298031A1
    • 2007-12-27
    • US11881759
    • 2007-07-26
    • Michael BrinesAnthony CeramiCarla Cerami Hand
    • Michael BrinesAnthony CeramiCarla Cerami Hand
    • A61K38/19A61K35/00A61K39/395A61P21/00A61P29/00A61P9/10
    • A61K38/1816
    • Methods and compositions are provided for protecting or enhancing excitable tissue function in mammals by systemic administration of an erythropoietin receptor activity modulator, such as erythropoietin, which signals via an EPO-activated receptor to modulate the function of excitable tissue. Excitable tissues include central neuronal tissues, such as the brain, peripheral neuronal tissues, retina, and heart tissue. Protection of excitable tissues provides treatment of hypoxia, seizure disorders, neurodegenerative diseases, hypoglycemia, and neurotoxin poisoning. Enhancement of function is useful in learning and memory. The invention is also directed to compositions and methods for facilitating the transport of molecules across endothelial cell tight junction barriers, such as the blood-brain barrier, by association of molecules with an erythropoietin receptor activity modulator, such as an erythropoietin.
    • 通过全身给予促红细胞生成素受体活性调节剂如红细胞生成素,通过EPO激活的受体信号调节可兴奋组织的功能,提供了用于保护或增强哺乳动物可激发组织功能的方法和组合物。 可兴奋组织包括中枢神经元组织,如脑,周围神经元组织,视网膜和心脏组织。 保护可兴奋组织提供治疗缺氧,癫痫发作,神经退行性疾病,低血糖症和神经毒素中毒。 功能的增强在学习和记忆中是有用的。 本发明还涉及通过分子与促红细胞生成素受体活性调节剂如红细胞生成素的缔合促进分子穿过内皮细胞紧密连接屏障(例如血脑屏障)的转运的组合物和方法。
    • 6. 发明授权
    • Methods for treatment and prevention of neuromuscular and muscular conditions by peripherally administered erythropoietin
    • 通过外周给予的促红细胞生成素治疗和预防神经肌肉和肌肉状况的方法
    • US07309687B1
    • 2007-12-18
    • US09717053
    • 2000-11-21
    • Michael BrinesAnthony CeramiCarla Cerami
    • Michael BrinesAnthony CeramiCarla Cerami
    • A61K38/18
    • A61K38/1816
    • Methods and compositions are provided for protecting or enhancing excitable tissue function in mammals by systemic administration of an erythropoietin receptor activity modulator, such as erythropoietin, which signals via an EPO-activated receptor to modulate the function of excitable tissue. Excitable tissues include central neuronal tissues, such as the brain, peripheral neuronal tissues, retina, and heart tissue. Protection of excitable tissues provides treatment of hypoxia, seizure disorders, neurodegenerative diseases, hypoglycemia, and neurotoxin poisoning. Enhancement of function is useful in learning and memory. The invention is also directed to compositions and methods for facilitating the transport of molecules across endothelial cell tight junction barriers, such as the blood-brain barrier, by association of molecules with an erythropoietin receptor activity modulator, such as an erythropoietin.
    • 通过全身给予促红细胞生成素受体活性调节剂如红细胞生成素,通过EPO激活的受体信号调节可兴奋组织的功能,提供了用于保护或增强哺乳动物可激发组织功能的方法和组合物。 可兴奋组织包括中枢神经元组织,如脑,周围神经元组织,视网膜和心脏组织。 保护可兴奋组织提供治疗缺氧,癫痫发作,神经退行性疾病,低血糖症和神经毒素中毒。 功能的增强在学习和记忆中是有用的。 本发明还涉及通过分子与促红细胞生成素受体活性调节剂如红细胞生成素的缔合促进分子穿过内皮细胞紧密连接屏障(例如血脑屏障)的转运的组合物和方法。